WCN26-8039 COMPARATIVE EFFICACY, SAFETY, AND ADHERENCE OF ONCE-DAILY VERSUS TWICE-DAILY TACROLIMUS IN ADULT KIDNEY TRANSPLANT RECIPIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Read full text Summarise with VIRAT
Authors: Ni Wayan Anantika Riani, I Gde Raka Widiana, Yenny Kandarini
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Tacrolimus is the cornerstone of maintenance immunosuppression after kidney transplantation. The once-daily prolonged-release formulation was developed to simplify dosing and potentially improve adherence relative to the conventional twice-daily immediate-release regimen. The comparative efficacy, safety, and adherence of these formulations remain uncertain.

Fields of Study & Subjects

Renal Transplantation Outcomes and Treatments Transplantation: Methods and Outcomes Medication Adherence and Compliance

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105543–105543
Publication date
25 March 2026
Language
EN